Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
Okonogi N, Usui H, Murata K, Hori M, Kurokawa T, Fujiwara T, Fujii Y, Hanawa M, Kawasaki Y, Hattori Y, Suzuki K, Tsuyuki K, Wakatsuki M, Hasegawa S, Yamada S, Hanaoka H, Shozu M, Tsuji H. Okonogi N, et al. Among authors: hanaoka h. BMJ Open. 2022 Mar 2;12(3):e056424. doi: 10.1136/bmjopen-2021-056424. BMJ Open. 2022. PMID: 35236732 Free PMC article.
Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).
Mitsuhashi A, Kawasaki Y, Hori M, Fujiwara T, Hanaoka H, Shozu M. Mitsuhashi A, et al. Among authors: hanaoka h. BMJ Open. 2020 Feb 28;10(2):e035416. doi: 10.1136/bmjopen-2019-035416. BMJ Open. 2020. PMID: 32114477 Free PMC article. Clinical Trial.
Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial.
Ogasawara S, Koroki K, Makishima H, Wakatsuki M, Takahashi A, Yumita S, Nakagawa M, Ishino T, Ogawa K, Fujiwara K, Iwanaga T, Sakuma T, Fujita N, Kojima R, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Ozawa Y, Kawasaki Y, Kurokawa T, Hanaoka H, Tsuji H, Kato N. Ogasawara S, et al. Among authors: hanaoka h. BMJ Open. 2022 Apr 8;12(4):e059779. doi: 10.1136/bmjopen-2021-059779. BMJ Open. 2022. PMID: 35396315 Free PMC article.
Evaluating the efficacy and safety of transdermal electrical stimulation on the visual functions of patients with retinitis pigmentosa: a clinical trial protocol for a prospective, multicentre, randomised, double-masked and sham-controlled design (ePICO trial).
Miura G, Ozawa Y, Shiko Y, Kawasaki Y, Iwase T, Fujiwara T, Baba T, Hanaoka H, Yamamoto S. Miura G, et al. Among authors: hanaoka h. BMJ Open. 2022 May 6;12(5):e057193. doi: 10.1136/bmjopen-2021-057193. BMJ Open. 2022. PMID: 35523495 Free PMC article.
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N, Miyazaki T, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Kurokawa T, Kawasaki Y, Hanawa M, Fujii Y, Hanaoka H, Iwami S, Watashi K, Yamagoe S, Miyazaki Y, Wakita T, Izumikawa K, Yanagihara K, Mukae H, Kohno S; Nelfinavir Study Group. Hosogaya N, et al. Among authors: hanaoka h. Trials. 2021 Apr 28;22(1):309. doi: 10.1186/s13063-021-05282-w. Trials. 2021. PMID: 33910617 Free PMC article.
Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.
Fujita M, Shimazu M, Nagashima K, Suzuki M, Tauchi I, Sakuma M, Yamamoto S, Shozu M, Hanaoka H, Tsuruoka N, Kasai T, Hata A. Fujita M, et al. Among authors: hanaoka h. BMJ Open. 2022 Feb 3;12(2):e049803. doi: 10.1136/bmjopen-2021-049803. BMJ Open. 2022. PMID: 35115348 Free PMC article.
HAMAMATSU-ICG study: Protocol for a phase III, multicentre, single-arm study to assess the usefulness of indocyanine green fluorescent lymphography in assessing secondary lymphoedema.
Akita S, Unno N, Maegawa J, Kimata Y, Fukamizu H, Yabuki Y, Shinaoka A, Sano M, Kawasaki Y, Fujiwara T, Hanaoka H, Mitsukawa N. Akita S, et al. Among authors: hanaoka h. Contemp Clin Trials Commun. 2020 Jun 16;19:100595. doi: 10.1016/j.conctc.2020.100595. eCollection 2020 Sep. Contemp Clin Trials Commun. 2020. PMID: 32617434 Free PMC article.
A phase III, multicenter, single-arm study to assess the utility of indocyanine green fluorescent lymphography in the treatment of secondary lymphedema.
Akita S, Unno N, Maegawa J, Kimata Y, Fukamizu H, Yabuki Y, Kitayama S, Shinaoka A, Yamada K, Sano M, Ota Y, Ohnishi F, Sakuma H, Nuri T, Ozawa Y, Shiko Y, Kawasaki Y, Hanawa M, Fujii Y, Imanishi E, Fujiwara T, Hanaoka H, Mitsukawa N. Akita S, et al. Among authors: hanaoka h. J Vasc Surg Venous Lymphat Disord. 2022 May;10(3):728-737.e3. doi: 10.1016/j.jvsv.2021.09.006. Epub 2021 Sep 27. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 34592477
LCAT-trial-24 weeks: Protocol for a clinical study to evaluate the safety of regenerative medicine and gene therapy by the autologous transplantation of human lecithin:cholesterol acyltransferase gene-transduced human pre-adipocytes.
Kuroda M, Hori M, Maezawa Y, Kubota Y, Mitsukawa N, Shiko Y, Ozawa Y, Kawasaki Y, Saito Y, Hanaoka H, Yokote K. Kuroda M, et al. Among authors: hanaoka h. Contemp Clin Trials Commun. 2022 Jun 9;28:100946. doi: 10.1016/j.conctc.2022.100946. eCollection 2022 Aug. Contemp Clin Trials Commun. 2022. PMID: 35734220 Free PMC article.
340 results